Please login to the form below

Not currently logged in
Email:
Password:

RCC

This page shows the latest RCC news and features for those working in and with pharma, biotech and healthcare.

NICE clears Ipsen’s Cabometyx in first-line kidney cancer

NICE clears Ipsen’s Cabometyx in first-line kidney cancer

The UK’s cost-effectiveness watchdog NICE has recommended first-line use of Ipsen’s Cabometyx for treatment-naïve patients with advanced renal cell carcinoma (RCC), the most common form of ... Hickling added: “This reimbursement decision reflects

Latest news

More from news
Approximately 11 fully matching, plus 53 partially matching documents found.

Latest Intelligence

  • Accelerating innovation Accelerating innovation

    Although marketed as the orphan drug Cometriq for thyroid neoplasms, it’s as Cabometyx in renal cell carcinoma (RCC) where the firm views real potential. ... Approved in Europe as a treatment for advanced RCC, Cabometyx won backing from NICE at its

  • Charting a course for expansion Charting a course for expansion

    I think these is some really game-changing data for first-line and second-line RCC patients.”. ... It showed that Cabometyx can decrease the rate of disease progression or death by 31% in advanced renal cell carcinoma (RCC).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics